February 6, 2008 -- AsiaPharm Group (SI: ASPH) received an offer from private equity firm MBK Partners to take the company private for $253 million. MBK has been assured that stockholders holding 44% of the outstanding shares will vote in favor of the proposal. AsiaPharm is listed on the Singapore exchange, but its operations are in China. MBK, which manages $1.5 billion, is based in the Cayman Islands and focuses on Asia. We look at the deal. More details...
